
Our Leaders
Advisory Board

Daniel MARSHAK, Ph.D.
Scientific Advisory & Corporate Strategy
Dr. Marshak an provides overall direction in R&D for PHASE Scientific.
An industry veteran who was formerly Senior Vice President, Chief Scientific Officer and President of Greater China of Perkin Elmer (NYSE: PKI), Dan holds a number of board directorships, including InVivo Therapeutics (NASDAQ: NVIV) and Upside Biotechnologies. He is also Chief Scientific Officer of Ferghana Partners and Advisor at 5AM Ventures.
Dan earned his Ph.D. in Biochemistry from Rockefeller University, United States

Daniel KAMEI, Ph.D.
Advisor - Science, Co-Founder - PHASE Diagnostics
Dr. Kamei is currently a Professor in the Department of Bioengineering at the University of California, Los Angeles, United States. He joined the faculty in 2003, and his research in paper microfluidic concentration has significantly impacted the core technology of PHASE. His work aims to continue to develop new technology to push the frontiers of diagnostics.
Professor Kamei has received multiple research awards, including the Coulter Early Career Award and the Kimmel Scholar Award. In addition to his research, Professor Kamei is also a dedicated teacher, and has been recognized by multiple teaching awards at UCLA, including the UCLA Academic Senate Distinguished Teaching Award and the Lockheed Martin Excellence in Teaching Award.

Jeffrey KLAUSNER, M.D., M.P.H.
Advisor - Science
Professor Klausner is an international expert in the prevention and control of infectious diseases, particularly of HIV, sexually transmitted diseases (STDs) and tuberculosis (TB). He is a frequent advisor to the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the World Health Organization.
Professor Klausner was previously Director of STD Prevention and Control for the San Francisco Department of Public Health. He was also the Branch Chief for HIV and TB for CDC in Pretoria, South Africa, where he helped lead The United States President’s Emergency Plan for AIDS Relief program there. He is a Clinical Professor of Medicine, Population and Public Health Sciences at Keck School of Medicine of the University of Southern California.










